PTEN and cholangiocarcinoma: Moreover, patients with high HSP90 protein expression and PTEN loss had the worst survival according to multivariate analyses (Table 4), which suggested that combining a PI3K inhibitor with an HSP90 inhibitor may represent an effective treatment for CCA.